
High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.
Publication
, Journal Article
Blanchard, SK; Sullivan, KM; Hooten, JN; Holcomb, ZE; Rowe Nichols, K; Selim, MA; Rao, CL; Hall, RP; Chao, NJ; Cardones, AR
Published in: Br J Dermatol
October 2019
Duke Scholars
Published In
Br J Dermatol
DOI
EISSN
1365-2133
Publication Date
October 2019
Volume
181
Issue
4
Start / End Page
869 / 871
Location
England
Related Subject Headings
- Treatment Outcome
- Transplantation, Homologous
- Skin Diseases
- Skin
- Severity of Illness Index
- Middle Aged
- Male
- Immunoglobulins, Intravenous
- Humans
- Hematopoietic Stem Cell Transplantation
Citation
APA
Chicago
ICMJE
MLA
NLM
Blanchard, S. K., Sullivan, K. M., Hooten, J. N., Holcomb, Z. E., Rowe Nichols, K., Selim, M. A., … Cardones, A. R. (2019). High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol, 181(4), 869–871. https://doi.org/10.1111/bjd.18028
Blanchard, S. K., K. M. Sullivan, J. N. Hooten, Z. E. Holcomb, K. Rowe Nichols, M. A. Selim, C. L. Rao, R. P. Hall, N. J. Chao, and A. R. Cardones. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.” Br J Dermatol 181, no. 4 (October 2019): 869–71. https://doi.org/10.1111/bjd.18028.
Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, et al. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol. 2019 Oct;181(4):869–71.
Blanchard, S. K., et al. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.” Br J Dermatol, vol. 181, no. 4, Oct. 2019, pp. 869–71. Pubmed, doi:10.1111/bjd.18028.
Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, Rao CL, Hall RP, Chao NJ, Cardones AR. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol. 2019 Oct;181(4):869–871.

Published In
Br J Dermatol
DOI
EISSN
1365-2133
Publication Date
October 2019
Volume
181
Issue
4
Start / End Page
869 / 871
Location
England
Related Subject Headings
- Treatment Outcome
- Transplantation, Homologous
- Skin Diseases
- Skin
- Severity of Illness Index
- Middle Aged
- Male
- Immunoglobulins, Intravenous
- Humans
- Hematopoietic Stem Cell Transplantation